COMPARISON OF RECOMMENDED SCREENING PROGRAMS IN THE UNITED STATES, CANADA, THE NETHERLANDS AND GERMANY
https://doi.org/10.17749/2070-4909.2016.9.4.046-053
Abstract
This publication presents a comparison of recommendations of screening programs and prevention activities in the United States, Canada, the Netherlands and Germany for adult non-pregnant population excluding infectious diseases. Sources of funding for such programs and information about their implementation are descripted. According to the search results of the relevant information in open sources, a list of recommended screening programs, as well as the amount of available information describing these programs in foreign countries varies.
About the Authors
V. S. DombrovskiyRussian Federation
researcher at the Laboratory for Health Technology Assessment at the Institute of Applied Economic Research of the Russian Presidential Academy of National Economy and Public Administration. Address: Vernadskogo prospect, 82-1, Moscow, Russia, 119571. Tel.: +7(499)9569528
G. R. Khachatryan
Russian Federation
researcher at the Laboratory for Health Technology Assessment at the Institute of Applied Economic Research of the Russian Presidential Academy of National Economy and Public Administration, junior researcher of the Center for Healthcare Funding of the Financial Scientific Research Institute at the Ministry of Finance of the Russian Federation. Address: Vernadskogo prospect, 82-1, Moscow, Russia, 119571. Tel.: +7(499)9569528
References
1. Avksent’eva M. V., Omel’yanovskii V. V. Meditsinskie tekhnologii. Otsenka i vybor. 2010; 1: 52-58.
2. Pyadushkina E. A., Avksent’eva M. V., Omel’yanovskii V. V. Meditsinskie tekhnologii. Otsenka i vybor. 2016; 3: 20-33.
3. Chto takoe Medicare? URL: https://www.medicare.gov/pubs/pdf/other-languages-not-sp/11306-R.pdf. Accessed: 25.11.2016
4. Andermann A., Blancquaert I., Beauchamp S., Dйry V. Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years. Bull World Health Organ. 2008; 86 (4): 317-319. URL: http://www.who.int/bulletin/volumes/86/4/07- 050112/en/. Accessed: 25.11.2016
5. Atrial Fibrillation. URL: http://canadiantaskforce.ca/appraised-guidelines/2014-atrial-fibrillation/. Accessed: 25.11.2016
6. Colorectal Cancer (2016). URL: http://canadiantaskforce.ca/ctfphc-guidelines/2015-colorectal-cancer/. Accessed: 25.11.2016
7. Early detection examinations covered by statutory health insurance. URL: http://www.english.g-ba.de/special-topics/prevention/detection/. Accessed: 25.11.2016
8. Holland W. W., Stewart S. Screening in Disease Prevention: What Works? Oxford: Radcliffe Publishing Ltd in association with The Nuffield Trust and the European Observatory on Health Systems and Policies. 2005. URL: http://www.euro.who.int/__data/assets/pdf_file/0007/108961/E88698.pdf. Accessed: 25.11.2016
9. Lung Cancer (2016). URL: http://canadiantaskforce.ca/ctfphc-guidelines/2015-lung- cancer/. Accessed: 25.11.2016
10. Melanoma. URL: http://canadiantaskforce.ca/appraised-guidelines/2013-melanoma/. Accessed: 25.11.2016
11. Obesity in Adults (2015). URL: http://canadiantaskforce.ca/ctfphc-guidelines/2015-obesity-adults/. Accessed: 25.11.2016
12. Osteoporosis. URL: http://canadiantaskforce.ca/appraised-guidelines/2013-osteoporosis/. Accessed: 25.11.2016
13. Population Screening Act: Renewal of nationwide cervical cancer screening programme. URL: https://www.gezondheidsraad.nl/en/task-and-procedure/areas-of- activity/prevention/population-screening-act-renewal-of-nationwide. Accessed: 25.11.2016
14. Population Screening Act: study of faecal tests within the population based screening programme for colorectal cancer. URL: https://www.gezondheidsraad.nl/en/task-and-procedure/areas-of-activity/prevention/population-screening-act-study-of-faecal-tests. Accessed: 25.11.2016
15. Population Screening Act: pressureguided compression for breast cancer screening. URL: https://www.gezondheidsraad.nl/en/task-and-procedure/areas-of-activity/prevention/population-screening-act-pressureguided-compression. Accessed: 25.11.2016
16. Preventive & screening services. URL: https://www.medicare. gov/coverage/preventive-and-screening-services.html. Accessed: 25.11.2016
17. Screening for Breast Cancer (2011). URL: http://canadiantaskforce.ca/ctfphc- guidelines/2011-breast-cancer/. Accessed: 25.11.2016
18. Screening for Cervical Cancer (2013). URL: http://canadiantaskforce.ca/ctfphc- guidelines/2013-cervical-cancer/. Accessed: 25.11.2016
19. Screening for Depression (2013). URL: http://canadiantaskforce.ca/ctfphc- guidelines/2013-depression/. Accessed: 25.11.2016
20. Screening for Hypertension (2012). URL: http://canadiantaskforce.ca/ctfphc-guidelines/2012-hypertension/. Accessed: 25.11.2016
21. Screening for Prostate Cancer (2014). URL: http://canadiantaskforce.ca/ctfphc-guidelines/2014-prostate-cancer/. Accessed: 25.11.2016
22. Screening for Type 2 Diabetes (2012). URL: http://canadiantaskforce.ca/ctfphc- guidelines/2012-type-2-diabetes/. Accessed: 25.11.2016
23. Seedat F., Cooper J., Stranges S., Kandala N. B., Taylor-Phillips S. International comparisons of screening policy-making: A systematic review. National Screening Committee. 2014. URL: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/444227/FI NAL_REPORT_International_Screening.pdf. Accessed: 25.11.2016
24. USPSTF A and B Recommendations. U. S. Preventive Services Task Force. April 2016. URL: http://www.uspreventiveservicestaskforce.org/Page/Name/uspstf-a-and-b- recommendations/. Accessed: 25.11.2016
Review
For citations:
Dombrovskiy V.S., Khachatryan G.R. COMPARISON OF RECOMMENDED SCREENING PROGRAMS IN THE UNITED STATES, CANADA, THE NETHERLANDS AND GERMANY. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2016;9(4):46-53. (In Russ.) https://doi.org/10.17749/2070-4909.2016.9.4.046-053

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.